Dr. Raoul Tibes

Dr. Raoul Tibes

Clinical Leukemia Program Director
NYU Langone Health

Dr. Raoul Tibes was formerly the Director of the Clinical Leukemia Program at NYU Langone Health’s Perlmutter Cancer Center.

He completed a hematology-oncology fellowship at MD Anderson Cancer Center, and has since dedicated his work to advancing clinical care of leukemia patients by bringing the latest science to patients.

Symptoms & Diagnosis

After an AML Diagnosis, Knowing Your Risk Group is Important for Treatment

Relapse

New Options For Acute Myeloid Leukemia (AML) Relapse: Combination Therapies with Gilteritinib

Relapse

What is The Treatment For Acute Myeloid Leukemia (AML) Patients After Relapse: Gilteritinib And FLT3 Inhibitors

Relapse

What Are The Options For Patients When Acute Myeloid Leukemia (AML) Returns?

Treatment

The Benefits of Combination Drug Therapy Using Ventecolax for AML

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.